Intravenous Immunoglobulin Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2020 to 2025

(Heraldkeepers via Comtex)

A recent report on Intravenous Immunoglobulin Market provides a detailed analysis on the industry size, revenue forecasts and geographical landscape pertaining to this business space. Additionally, the report highlights primary obstacles and latest growth trends accepted by key players that form a part of the competitive spectrum of this business.

Intravenous Immunoglobulin Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025- Growing geriatric population, rising prevalence of immunodeficiency diseases, increasing adoption of IVIG treatments and rising use of off-label indications are the key drivers of the Global Intravenous Immunoglobulin Market.

Intravenous Immunoglobulin Market is valued at USD 9804.8 Million in 2018 and expected to reach USD 16587.0 Million by 2025 with CAGR of 7.80% over the forecast period.

Get Sample Copy of This Premium Report https://brandessenceresearch.com/requestSample/PostId/513

**The sample pages of this report is immediately accessible on-demand.**

Intravenous Immunoglobulin (IVIg), a compound comprising of immune proteins (globulins) is administered into the bloodstream to treat patients with inefficient or damaged immune systems. IVIg provides the required antibodies to the human body to fight out the immune deficiency, and the ensuing infectious attacks. Immunoglobulin also referred as antibodies, are the glycoprotein molecules manufactured by the plasma or white blood cells. Immunoglobulin's form a very critical line of defense of the immune system by specially recognizing and binding itself to particular antigens such as bacteria and viruses and aid in their destruction. In certain individual, immunoglobulins have to be administered for the treatment and management of disease such as primary immunodeficiency (PI). Intravenous immunoglobulins are the most popular form of immunoglobulin due to the no requirement for self-administration and the easy administration in hospital and clinic settings. Different classes of immunoglobulin such as IgA, IgG, and IgM are used for the treatment of various neurological and immunological diseases.

Global Intravenous Immunoglobulin market report is segmented on the basis of type, application, end-users and region & country level. Based on type, global intravenous immunoglobulin market is classified into IgG, IgA, IgM, IgE and IgD. Based on application global intravenous immunoglobulin market is classified into hypogammaglobulinemia, immunodeficiency diseases, congenital AIDS, chronic inflammatory demyelinating polyneuropathy, myasthenia gravis, multifocal motor neuropathy, ITP, Guillain-Barre syndrome, Kawasaki Diseases and others. Based on end-user, global intravenous immunoglobulin market is classified into hospitals, clinics, homecare and others.

The regions covered in this intravenous immunoglobulin market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of intravenous immunoglobulin is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players-

Global intravenous immunoglobulin market report covers prominent players like Omrix Biopharmaceuticals Ltd., Hualan Biological Engineering Inc., Shanghai RAAS Blood Products Co. Ltd., Behring GmbH, Option Care Enterprises, Inc., BioScrip, Inc, ADMA Biologics, Inc., CSL Ltd., Baxter International Inc., Kedrion Biopharma Inc., Grifols S.A, LFB group, Octapharma AG, ADMA Biologics, Inc., China Biologics Products, Inc., Biotest AG, Takeda Pharmaceuticals and among others.

Market Dynamics-

Rising elderly population, increasing occurrence of immunodeficiency disorders, growing implementation of IVIG procedures and increasing usage of off-label indications are some of the major factors driving the market growth. Increasing number of patients with immunodeficiency disease is the primary reason for the expansion of IVIG procedures. According to the World Health Organization (WHO), there are approximately 50 diverse Primary Immune Deficiency (PID) such as X-lined hypo-gamma-globulinemia, specific antibody deficiency and others. Furthermore, according to the U.S. National Library of Medicine and National Institute of Health, around 6 million patients are suffering from Primary Immune Deficiency (PID) globally. Rising occurrences of these immune diseases is expected to foster the demand for intravenous immunoglobulin treatments during the forecast period. However, stringent government regulations regarding the use of intravenous immunoglobulin products and high risk of side effects associated with them are expected to hinder the growth of the market. Moreover, high adoption of intravenous immunoglobulins for the treatment of various diseases is expected to create lucrative opportunities in the near future.

Regional Analysis-

North America is expected to dominate the global intravenous immunoglobulin market. Increasing healthcare expenditure, growing level of consciousness for the products involved in the treatment of immunodeficiency disorders, and rising inclination of clinicians towards immunodeficiency therapies are the key factors attributing towards the market growth. Additionally, growing occurrences of primary immunodeficiency (PID) is also expected to enhance the market growth in this region. According to American Autoimmune Related Disease Association Inc. (AARDA) 2012, approximately 50 million Americans were diagnosed to have autoimmune diseases and the number of people suffering this disease.

Asia Pacific is expected to show a significant growth at a considerable CAGR over forecast period owing to the increasing awareness and potential opportunities for adoption of immunoglobulin based therapies for the treatment of primary immune deficiencies coupled with growing geriatric population in this region.

Key Benefits for Market Report-

  • Global Intravenous Immunoglobulin Market report covers in depth historical and forecast analysis.
  • Global Intravenous Immunoglobulin Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global Intravenous Immunoglobulin Market report helps to identify opportunities in market place.
  • Global Intravenous Immunoglobulin Market report covers extensive analysis of emerging trends and competitive landscape.

Market Segmentation:-

By Type:

  • IgG
  • IgA
  • IgM
  • IgE
  • IgD

By Application:

  • Hypogammaglobulinemia
  • Immunodeficiency Diseases
  • Congenital AIDS
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Myasthenia Gravis
  • Multifocal Motor Neuropathy
  • ITP
  • Guillain-Barre syndrome
  • Kawasaki Diseases
  • Others

By End-Users:

  • Hospitals
  • Clinics
  • Homecare
  • Others

By Regional & Country Analysis:

  • North America
    • U.S.
    • Mexico
    • Canada
  • Europe
    • U.K
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
  • The Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Intravenous Immunoglobulin Market Size Growth Rate by Type (2014-2025)
1.4.2 Topical Products
1.4.3 Botulinum
1.4.4 Dermal Fillers
1.4.5 Chemical Peels
1.4.6 Microabrasion Equipment
1.4.7 Laser Surfacing Treatments
1.5 Market by Application
1.5.1 Global Intravenous Immunoglobulin Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Dermatology Clinics
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Intravenous Immunoglobulin Market Size
2.2 Intravenous Immunoglobulin Growth Trends by Regions
2.2.1 Intravenous Immunoglobulin Market Size by Regions (2014-2025)
2.2.2 Intravenous Immunoglobulin Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Intravenous Immunoglobulin Market Size by Manufacturers
3.1.1 Global Intravenous Immunoglobulin Revenue by Manufacturers (2014-2019)
3.1.2 Global Intravenous Immunoglobulin Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Intravenous Immunoglobulin Market Concentration Ratio (CR5 and HHI)
3.2 Intravenous Immunoglobulin Key Players Head office and Area Served
3.3 Key Players Intravenous Immunoglobulin Product/Solution/Service
3.4 Date of Enter into Intravenous Immunoglobulin Market
3.5 Mergers & Acquisitions, Expansion Plans

Get Full Report:https://brandessenceresearch.com/healthcare/intravenous-immunoglobulin-market-trend

About Us: Brandessence Market Research and Consulting Pvt. ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact us at: +44-2038074155 or mail us at [email protected]

Article: https://businessstatsnews.com Blog: http://www.dailyindustrywatch.com Blog: https://marketsize.biz Blog: https://technologyindustrynews.com Blog: https://marketstatsreport.com Website: https://brandessenceresearch.com/ Blog:https://tcbiznews.com/

 

comtex tracking